This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. 
The life sciences bpo market size has grown rapidly in recent years. It will grow from $266.44 billion in 2024 to $295.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to focus on patient-centric healthcare solutions, increasing data management challenges, market competition and time-to-market pressure, globalization and expansion, complexity in clinical trials.
The life sciences bpo market size is expected to see strong growth in the next few years. It will grow to $431.96 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for drug development support, focus on real-world evidence and data analytics, globalization and expansion strategies, increased emphasis on precision medicine, rise in outsourcing clinical trial management. Major trends in the forecast period include ai and advanced analytics integration, virtual trials and remote monitoring, focus on regulatory compliance solutions, precision medicine and personalized healthcare, blockchain and data security solutions.
The increasing healthcare expenditure is expected to drive the growth of the life sciences BPO market in the future. Healthcare expenditure refers to the total spending on healthcare-related goods and services, covering a wide range of categories such as medical treatments, medications, hospital stays, doctor visits, medical devices, health insurance, and other healthcare-related expenses. Life sciences BPO solutions support healthcare companies in delivering essential drugs, devices, and services to patients. The growing healthcare investments further enhance their ability to optimize costs, speed up development, accelerate the introduction of new treatments to the market, and lower research and development costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, a faster growth rate than the 3.2% increase in 2021. Therefore, the rise in healthcare expenditure is fueling the growth of the life sciences BPO market.
Clinical trials support is expected to play a crucial role in propelling the growth of the life sciences BPO market going forward. Clinical trials support involves the services and activities that facilitate and manage clinical trials, which are research studies with human participants aimed at assessing the safety and effectiveness of new medical treatments, drugs, therapies, medical devices, or interventions. Professionals in clinical trials support help maintain the quality and integrity of clinical trial data, ensuring compliance with regulatory standards. This focus on data quality is vital for BPO providers managing clinical trial data, often a core service for life sciences companies. For example, in May 2023, Xtalks, a Canada-based digital health company, reported that there were 452,604 clinical trials registered globally as of May 17, 2023. Of these, 64,838 were actively recruiting participants. This represents a significant increase compared to more than 365,000 registered trials reported in early 2021. Therefore, clinical trials support is driving the growth of the life sciences BPO market.
Major companies in the life sciences BPO market are adopting a strategic partnership approach to develop innovative solutions. These partnerships allow life sciences BPO firms to combine resources and expertise, boosting research and development capabilities, expanding market reach, and accelerating commercialization, ultimately fostering innovation and growth in the industry. For example, in March 2024, Cognizant Technology Solutions Corp, a US-based company, formed a partnership with NVIDIA, a US-based software company. Through this collaboration, the two companies aim to accelerate drug discovery by leveraging NVIDIA's BioNeMo generative AI platform, which enables faster and more efficient analysis of complex datasets. The goal of this partnership is to enhance research capabilities and speed up the development of life-saving treatments.
In September 2022, Infosys Limited, an India-based IT company, acquired BASE life science for an undisclosed amount. This acquisition aims to enhance Infosys' expertise in the life sciences sector by incorporating BASE life science’s consulting and technology capabilities. The goal is to drive innovation in clinical trials and drug development, ultimately improving health outcomes through advanced data and cloud solutions. BASE life science, a Denmark-based information technology consulting firm, specializes in providing technology solutions and consulting services to the life sciences industry, with a focus on areas such as data science, digital marketing, clinical trials, and regulatory compliance.
Major companies operating in the life sciences bpo market report are Accenture PLC, Atos SE, Catalent Inc., Covance Inc., Genpact Ltd., ICON PLC, Infosys Ltd., Lonza Group, PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., ProMab Biotechnologies Inc., Cognizant Technology Solutions, Syneos Health Inc., R1 RCM Inc., Charles River Laboratories International Inc., Sartorius AG, WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., FAREVA Unterach GmbH, Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.
Asia-Pacific was the largest region in the life sciences BPO market in 2024. The regions covered in the life sciences bpo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life sciences bpo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Life sciences BPO (Business Process Outsourcing) involves outsourcing various business processes of life sciences companies to third-party experts. These specialized services support life sciences firms in areas such as data management, regulatory compliance, and customer support within the life sciences sector.
The primary types of services included in life sciences BPO are pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing involves the delegation of specific tasks or functions related to drug development, manufacturing, and distribution processes to external service providers. These services find application in various areas, including clinical testing methods, environmental testing methods, and others. End-users of these services include hospitals and clinics, diagnostic laboratories, and others.
The life sciences BPO market research report is one of a series of new reports that provides life sciences BPO market statistics, including life sciences BPO industry global market size, regional shares, competitors with a life sciences BPO market share, detailed life sciences BPO market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences BPO industry. This life sciences BPO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The life sciences bpo market size has grown rapidly in recent years. It will grow from $266.44 billion in 2024 to $295.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to focus on patient-centric healthcare solutions, increasing data management challenges, market competition and time-to-market pressure, globalization and expansion, complexity in clinical trials.
The life sciences bpo market size is expected to see strong growth in the next few years. It will grow to $431.96 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for drug development support, focus on real-world evidence and data analytics, globalization and expansion strategies, increased emphasis on precision medicine, rise in outsourcing clinical trial management. Major trends in the forecast period include ai and advanced analytics integration, virtual trials and remote monitoring, focus on regulatory compliance solutions, precision medicine and personalized healthcare, blockchain and data security solutions.
The increasing healthcare expenditure is expected to drive the growth of the life sciences BPO market in the future. Healthcare expenditure refers to the total spending on healthcare-related goods and services, covering a wide range of categories such as medical treatments, medications, hospital stays, doctor visits, medical devices, health insurance, and other healthcare-related expenses. Life sciences BPO solutions support healthcare companies in delivering essential drugs, devices, and services to patients. The growing healthcare investments further enhance their ability to optimize costs, speed up development, accelerate the introduction of new treatments to the market, and lower research and development costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, a faster growth rate than the 3.2% increase in 2021. Therefore, the rise in healthcare expenditure is fueling the growth of the life sciences BPO market.
Clinical trials support is expected to play a crucial role in propelling the growth of the life sciences BPO market going forward. Clinical trials support involves the services and activities that facilitate and manage clinical trials, which are research studies with human participants aimed at assessing the safety and effectiveness of new medical treatments, drugs, therapies, medical devices, or interventions. Professionals in clinical trials support help maintain the quality and integrity of clinical trial data, ensuring compliance with regulatory standards. This focus on data quality is vital for BPO providers managing clinical trial data, often a core service for life sciences companies. For example, in May 2023, Xtalks, a Canada-based digital health company, reported that there were 452,604 clinical trials registered globally as of May 17, 2023. Of these, 64,838 were actively recruiting participants. This represents a significant increase compared to more than 365,000 registered trials reported in early 2021. Therefore, clinical trials support is driving the growth of the life sciences BPO market.
Major companies in the life sciences BPO market are adopting a strategic partnership approach to develop innovative solutions. These partnerships allow life sciences BPO firms to combine resources and expertise, boosting research and development capabilities, expanding market reach, and accelerating commercialization, ultimately fostering innovation and growth in the industry. For example, in March 2024, Cognizant Technology Solutions Corp, a US-based company, formed a partnership with NVIDIA, a US-based software company. Through this collaboration, the two companies aim to accelerate drug discovery by leveraging NVIDIA's BioNeMo generative AI platform, which enables faster and more efficient analysis of complex datasets. The goal of this partnership is to enhance research capabilities and speed up the development of life-saving treatments.
In September 2022, Infosys Limited, an India-based IT company, acquired BASE life science for an undisclosed amount. This acquisition aims to enhance Infosys' expertise in the life sciences sector by incorporating BASE life science’s consulting and technology capabilities. The goal is to drive innovation in clinical trials and drug development, ultimately improving health outcomes through advanced data and cloud solutions. BASE life science, a Denmark-based information technology consulting firm, specializes in providing technology solutions and consulting services to the life sciences industry, with a focus on areas such as data science, digital marketing, clinical trials, and regulatory compliance.
Major companies operating in the life sciences bpo market report are Accenture PLC, Atos SE, Catalent Inc., Covance Inc., Genpact Ltd., ICON PLC, Infosys Ltd., Lonza Group, PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., ProMab Biotechnologies Inc., Cognizant Technology Solutions, Syneos Health Inc., R1 RCM Inc., Charles River Laboratories International Inc., Sartorius AG, WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., FAREVA Unterach GmbH, Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.
Asia-Pacific was the largest region in the life sciences BPO market in 2024. The regions covered in the life sciences bpo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life sciences bpo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Life sciences BPO (Business Process Outsourcing) involves outsourcing various business processes of life sciences companies to third-party experts. These specialized services support life sciences firms in areas such as data management, regulatory compliance, and customer support within the life sciences sector.
The primary types of services included in life sciences BPO are pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing involves the delegation of specific tasks or functions related to drug development, manufacturing, and distribution processes to external service providers. These services find application in various areas, including clinical testing methods, environmental testing methods, and others. End-users of these services include hospitals and clinics, diagnostic laboratories, and others.
The life sciences BPO market research report is one of a series of new reports that provides life sciences BPO market statistics, including life sciences BPO industry global market size, regional shares, competitors with a life sciences BPO market share, detailed life sciences BPO market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences BPO industry. This life sciences BPO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Life Sciences BPO Market Characteristics3. Life Sciences BPO Market Trends and Strategies4. Life Sciences BPO Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Life Sciences BPO Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Life Sciences BPO Market34. Recent Developments in the Life Sciences BPO Market
5. Global Life Sciences BPO Growth Analysis and Strategic Analysis Framework
6. Life Sciences BPO Market Segmentation
7. Life Sciences BPO Market Regional and Country Analysis
8. Asia-Pacific Life Sciences BPO Market
9. China Life Sciences BPO Market
10. India Life Sciences BPO Market
11. Japan Life Sciences BPO Market
12. Australia Life Sciences BPO Market
13. Indonesia Life Sciences BPO Market
14. South Korea Life Sciences BPO Market
15. Western Europe Life Sciences BPO Market
16. UK Life Sciences BPO Market
17. Germany Life Sciences BPO Market
18. France Life Sciences BPO Market
19. Italy Life Sciences BPO Market
20. Spain Life Sciences BPO Market
21. Eastern Europe Life Sciences BPO Market
22. Russia Life Sciences BPO Market
23. North America Life Sciences BPO Market
24. USA Life Sciences BPO Market
25. Canada Life Sciences BPO Market
26. South America Life Sciences BPO Market
27. Brazil Life Sciences BPO Market
28. Middle East Life Sciences BPO Market
29. Africa Life Sciences BPO Market
30. Life Sciences BPO Market Competitive Landscape and Company Profiles
31. Life Sciences BPO Market Other Major and Innovative Companies
35. Life Sciences BPO Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Life Sciences BPO Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on life sciences bpo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for life sciences bpo? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The life sciences bpo market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Services: Pharmaceutical Outsourcing; Medical Devices Outsourcing; Contract Sales And Marketing Outsourcing; Other Services2) By Application: Clinical Testing Methods; Environmental Testing Methods; Other Applications
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Pharmaceutical Outsourcing: Drug Development Services; Clinical Trials Management; Regulatory Affairs Services; Pharmacovigilance2) By Medical Devices Outsourcing: Product Development Services; Regulatory Compliance; Quality Assurance And Testing; Supply Chain Management
3) By Contract Sales And Marketing Outsourcing: Sales Force Outsourcing; Marketing Strategy Development; Market Access And Pricing Strategies; Promotional Activities
4) By Other Services: Data Management And Analytics; IT Services; Training And Education; Consulting Services
Key Companies Mentioned: Accenture plc; Atos SE; Catalent Inc.; Covance Inc.; Genpact Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Life Sciences BPO market report include:- Accenture plc
- Atos SE
- Catalent Inc.
- Covance Inc.
- Genpact Ltd.
- ICON plc
- Infosys Ltd.
- Lonza Group
- PAREXEL International Corp.
- IQVIA Holdings Inc.
- International Business Machines Corp.
- ProMab Biotechnologies Inc.
- Cognizant Technology Solutions
- Syneos Health Inc.
- R1 RCM Inc.
- Charles River Laboratories International Inc.
- Sartorius AG
- WuXi AppTec Co. Ltd.
- Medpace Holdings Inc.
- Pharmaceutical Product Development LLC
- Medidata Solutions
- Health Decisions Inc.
- FAREVA Unterach GmbH
- Bioclinica Inc.
- Navitas Life Sciences Private Limited
- SGS SA
- PRA Health Sciences Inc.
- Clinipace Worldwide
- ClinTec International Ltd.
- Cromsource Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 295.37 Billion |
| Forecasted Market Value ( USD | $ 431.96 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
